Abstract The aim of this study is to test what effect the weather may have on medications prescribed to treat Parkinson's disease. Twenty-three years of monthly time, series data was sourced from the Pharmaceutical Benefits Scheme (PBS) and the Bureau of Meteorology (BOM). Data were available for eight states and territories and their corresponding capital cities. The dependent variable was the aggregate levodopa equivalent dose (LED) for 51 Parkinson's medications identified on the PBS. Two explanatory variables of interest, temperature and solar exposure, were identified in the BOM data set. Linear and cosinor models were estimated with fixed and random effects, respectively. The prescribed LED was 4.2% greater in January and 4.5% lower in July. Statistical analysis showed that temperature was associated with the prescription of Parkinson medications. Our results suggest seasonality exists in Parkinson's disease symptoms and this may be related to temperature. Further work is needed to confirm these findings and understand the underlying mechanisms as a better understanding of the causes of any seasonal variation in Parkinson's disease may help clinicians and patients manage the disease more effectively.
Introduction
Parkinson's disease (PD) is a chronic neurological disease, caused by a decreased production of the neural transmitter dopamine. A small number of studies, which have evaluated dopamine synthesis, report a seasonal variation (Eisenberg et al. 2010; Kaasinen et al. 2012; Karson et al. 1984 ). An analysis of 86 healthy adults living in the USA used positron emission tomography (PET) to measure putamen dopamine and reported greater synthesis during fall and winter as compared to spring and summer (Eisenberg et al. 2010) . Further, an investigation of 109 patients living with PD in Finland, also found an increased uptake of putamen dopamine in autumn and winter months compared to spring and summer (Kaasinen et al. 2012) .
However, an analysis of PD symptoms using the Unified Parkinson's Disease Rating Scale (UPDRS) in 546 patients treated in, Toronto, Canada, from 2000 to 2003, reported no seasonal variation. It was suggested that failure to control for adjustments to the patient's mediation regime and other confounding seasonal effects may have influenced this finding (Postuma et al. 2005 ). An investigation of hallucinations using the UPDRS (n = 51) also reported no fluctuation in clinical symptoms between winter and summer (Goetz et al. 2006) .
Other seasonal effects, including the date of birth have been hypothesised. Two small scale studies have suggested that a spring birth may be a risk factor for development of PD in later life (Mattock et al. 1988; Miura et al. 1987) ; however, subsequent analyses have not confirmed this proposition (Palladino et al. 2015; Gardener et al. 2010; Postuma et al. 2007) . Seasonal influenza has been reported to be associated with the severity of PD symptoms (Rohn and Catlin 2011) but not the risk of developing PD (Toovey et al. 2011) . Geographical differences have also been reported. The Western provinces in Canada (Svenson 1991) , the USA (Betemps and Buncher 1993) and the South Eastern provinces in China (Wang et al. 1991 ) are reported to have comparatively higher rates of PD than other regions within those countries. However, an Israeli study found no geographical differences in PD prevalence, within that much smaller nation (Anca et al. 2002) . Latitude is reported to be positively correlated with PD prevalence (Eisen and Calne 1992) and vitamin D has frequently been identified as a potential driver of this observed correlation (Newmark and Newmark 2007; Suzuki et al. 2012; Sato et al. 1997) .
A definitive physiological model that explains howthe weather could affect PD has not been established. However, we identified two potential elements, temperature and ultraviolet (UV) light. The brain is recognised as the most temperature-sensitive organ in the human body (Kiyatkin 2010) . In rat models, the functioning of substantia nigra pars compacta has been demonstrated to be heat sensitive. Cooling slowed the firing and cell membrane hyperpolarization, increased cell input resistance, generated an outward current under voltage clamp and decreased Ca 2+ , while warming induced the opposite effects (Guatteo et al. 2005) . In humans, the classical symptoms of PD (resting tremor, deficit and slowness of movement, muscle rigidity) can be elicited through hypothermia, suggesting lower temperatures exacerbate the clinical symptoms of PD (Meigal and Lupandin 2005) . Patients with PD have also been reported to have impaired brain temperature regulation resulting in elevated temperatures, which has been speculatively attributed to increased oxidative metabolism and/ or an uncoupling of ATP production from oxidation (Rango et al. 2012) .
Alternatively, UV B radiation (wavelength, 290-315 nm) is known to have a seasonal effect on the synthesis of cholecalciferol (vitamin D3) through its action of on 7-dehydrocholesterol in the skin (2012) and vitamin D is reported to reduce the probability of PD (Knekt et al. 2010; Ding et al. 2013; Newmark and Newmark 2007) and the severity of its symptoms (Sato et al. 1997; Peterson et al. 2013; Suzuki et al. 2013) . It has been hypothesised that healthy brain cells which normally absorb 25-OH vitamin D, may be damaged by hypovitaminosis D, resulting in degeneration of the substantia nigra and increased likelihood of PD (Newmark and Newmark 2007) . The synthesis of vitamin D is not immediate and variation in serum 25(OH)D will lag 8-10 weeks behind UVB radiation in Australia (Pittaway et al. 2013) .
Plausibly, seasonal variation in temperature and UV light could affect seasonal changes in the severity of PD. The analysis, which follows will systematically test these potential correlations.
Materials and methods
Monthly data from a national pharmaceutical registry and meteorological service were analysed. The assumption that underpins our analysis is that changes in either the number of presenting patients with PD or symptom severity will be reflected by changes in the aggregate levodopa equivalent dose (LED) prescribed to treat PD. At certain times of the year, individuals may be newly diagnosed with PD, or patients currently treated for PD may experience increased symptoms. Both phenomena could contribute to a seasonal fluctuation in the LED.
Data
The Australian Bureau of Meteorology (BoM) is the agency responsible for data collection and weather forecasting in Australia. Meteorological data were obtained from the BoM from the capital city in each state and territory (Bureau of Meteorology 2016). To obtain a representative time series, the weather station closest to each capital city's central business district (CBD), with a complete time series from 1992 to 2014 was selected (see Appendix 1). No selected weather station was more than eight kilometres from the CBD. Temperature reports a mean daily maximum in degrees Celsius (°C). Solar intensity was selected as a proxy for UV light and is measured in mega joules per square meter (MJ mm 2 ). Medicare Australia administers the Pharmaceutical Benefits Scheme (PBS), which is a publically funded insurance scheme that provides subsidised medications to Australia's 22 million inhabitants (Australian Bureau of Statistics 2008). Monthly aggregates are reported for every pharmaceutical claimed through the PBS from 1992 for all eight Australian states and territories. A search of the PBS identified 51 pharmaceuticals prescribed for the treatment of Parkinson's disease (see Table 1) A monthly LED for each pharmaceutical was estimated as follows:
Dose per tablet, tablets per prescription and prescriptions per month were reported for each pharmaceutical. Repeats per prescription were not reported; therefore, it was assumed there were zero repeats per prescription. For each pharmaceutical, a LED conversion factor (LED CF) was obtained from a metaanalysis of published studies (Tomlinson et al. 2010) .
The incentive to provide these data is strong as reimbursement is dependent on it. Typically, the pharmacists enter PBS claims into Medicare Australia systems in real time. Medicare Australia reports the date the claim for a rebate is lodged with the PBS, not the date the script was written by the physician, or supplied by the pharmacist. However, the majority of prescriptions are believed to be processed in the month the prescription is lodged with the pharmacist (van Gool et al. 2011) . Seasonal patterns in pharmaceutical prescription have been observed. The PBS requires that patients contribute a copayment until a safety net threshold is reached, after which medications are available free of charge for the remainder of the calendar year. This creates a financial incentive for an increase in utilisation towards the end of the calendar year (Donnelly et al. 2000; Hynd et al. 2008) .
Empirical approach
Our hypothesis is that the weather might cause more PD patients to present with increased symptoms, resulting in Australia's physicians to adjust seasonally the prescribed LED. The dependent variable of interest is LED, which is reported as monthly aggregates. The specification of our empirical models was guided as follows: any effect that a change in temperature has on the brain was assumed Bimmediate^and hence, temperature was analysed in the current month t. However, the scientific literature suggests that changes in UV light will have a delayed effect on PD because UV light is reported to affect PD through its synthesis of vitamin D (Nair and Maseeh 2012) . In Australia, changes in serum vitamin D levels lag UV light by 8-10 weeks (Pittaway et al. 2013) . Therefore, a lagged measure of solar intensity, t-2-months, was specified in our models.
Two empirical models were estimated; the first a linear model and the second a non-linear model.
Where Equation 1 is a log-log linear model, where the dependent variable LLED is the log of the aggregate LED. T is a trend term that was added to capture changes due to technological improvements and/or population growth. The explanatory The anticholinergic agents benzhexol, biperiden and benztropine and the dopaminergic agent entacapone were omitted from the national LED estimate because reliable LED CFs were not available and anticholinergic agents are not only used to treat PD SR slow release, CF conversion factor variable W is the log of an element of the weather (temperature or UV light). DM is a set of dummy variables, one for each month of the year, that were included to control for all sources of residual seasonal variation in the dependent variable LLED. The subscripts t and s denote time and state, respectively and ε is a random error term. Equation 2 is a cosinor model, which was included in our analysis because it is a simple and popular method for analysing seasonality. Its popularity stems from its parsimony, requiring only two parameters to model seasonality. This model assumes a sinusoidal seasonal pattern in the dependent variable. The parameter φ is the fraction of the seasonal cycle reported as radians. The coefficients on the cosine(φ t , s ) and sine(φ t , s ) terms are used to derive the season's phase and amplitude. Covariates can be added, and the coefficients interpreted, as in, a linear model. The cosinor model does, however, assume a symmetric sinusoidal pattern, which can be too restrictive for some seasonal data (Barnett and Dobson 2010) . The linear model, with its use of monthly dummy variables to control for seasonality, does not assume symmetry, and hence remains our preferred model.
A log transformation of the data was undertaken to both mitigate the effects of potential heteroscedasticity (see Fig. 1 ) and to provide easily interpretable results. The coefficients in a log-log regression reports the percentage change in the dependent variable attributed to a 1% increase in the explanatory variable (Wooldridge 2000) . Tests for stationarity using the Levin-Lin-Chu and Im-Pesaran-Shin tests rejected the hypothesis that the data has a unit root; the test results are robust with and without an assumption about the presences of a trend in the series. Estimation by fixed or random effects was determined by Hausman tests. Multicollinearity was identified as a potential source of bias. Therefore, temperature and solar intensity and its lagged terms were substituted for W in the linear and cosinor models. We also estimated a multivariate specification.
Results
Summary data, including a monthly time series of the national LED (Fig. 1a) and scatter plot of the average monthly LED, with means and 95% CI, (Fig. 1b) , are displayed in Fig. 1 . The data indicate a strong non-symmetrical seasonal pattern, with some increased variance at the end of the time series. Figure 2 reports a population-weighted average, temperature and solar intensity for Australia's eight capital cities (see Appendix 1 for city populations). Weighted means reflect the climate experienced by the majority of Australians, for any given month. Figure 2d reports monthly LED in tons and temperature and solar intensity in standardised units (μ = 0, σ = 1). A non-symmetric seasonal fluctuation in the LED is evident. The average prescribed LED is 1.61 (t) per month; and a maximum of 1.85 (t) in January and a minimum of 1.37 (t) in February. Table 2 reports the coefficients and corresponding p values for five selected weather variables derived from the linear (Eq. 1) and cosinor models (Eq. 2). The intercept terms and covariates for Eq. 1 (T and DM) and Eq. 2 (T, cosine, and sine) were statistically significant, but for parsimony are not reported. The results from both statistical models are similar. The linear and cosinor models reported that a 1% increase in temperature was associated with a 0.18% (p < 0.01) and 013% (p = 0.03) increase in the LED, respectively. Solar intensity was not statistically significant, nor was its one-month and two-month lags. A statistically significant coefficient of 0.18 implies that temperature is associated with a 4.2% increase in the LED in January and a 4.5% decrease in July.
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Multivariate specifications that included log temperature, and log solar intensity lagged 2 months, as explanatory variables were estimated. Temperature again remained statistically significant in both the linear [0.16 (p = 0.02)] and cosinor [0.12 (p = 0.08)] models. Lagged solar intensity (SI t-2 ) was not statistically significant in either multivariate model Two sensitivity analyses were conducted. Firstly, our models assume that the majority of PBS claims are processed in the month prescribed (van Gool et al. 2011) . If the time taken to process claims for PD scripts were longer than average; scripts processed in the following month (LLED t+1 ), may be the more sensitive to weather changes. When therefore reestimated with LLED t+1 as the dependent variable, temperature remained statistically significant in both the linear [0.22 (p < 0.01)] and cosinor models [0.17 (p < 0.01)]. Secondly, due volatility in the LED was observed in Fig. 1 after 2014 , the time series was truncated at January 2014 and the statistical models re-estimated. Temperature remained statistically significant in both the linear [0.19 (p < 0.01) ] and cosinor models [0.13 (p < 0.05)].
Discussion
Putamen dopamine plays an important role in the pathogenesis of PD and is reported to fluctuate seasonally (Eisenberg et al. 2010; Kaasinen et al. 2012; Karson et al. 1984) . Our aim was to test what effect if any the weather may have on the symptoms of PD. A positive and statistically significant correlation between temperature and LED was observed in the linear and cosinor models and sensitivity analyses. The linear model was preferred because it does not assume the seasonal 1 The monthly change in the LED is estimated by:
Â α 2 w m = Weighted monthly mean temperature w = Weighted annual mean temperature α 2 = 0.18 (see Table 2 ) variation in LED is symmetrical. Results from this specification indicate that temperature is associated with a seasonal fluctuation in the LED, increasing by 4.2% in summer (January) and decreasing by 4.5% in winter (July).
Previously published tests for seasonality in PD have failed to report a seasonal effect (Goetz et al. 2006; Postuma et al. 2005) . However, these studies analysed comparatively small samples for a short time. Goetz et al. (2006) analysed 51 (2005) analysed 541 participants for 2-3 years. Both studies aggregated their monthly data into Bseasons^, which may have reduced the sensitivity of their statistical tests for seasonality and neither study could identify a seasonal effect. However, our paper analyses 23 years of monthly pharmaceutical use for approximately 70,000 people living with PD in Australia (Deloitte Access Economics 2014). The seasonal variation in the LED we identify is consistent with clinical findings described by Kaasinen et al. (2012) . An increase in the synthesis of dopamine in PD patients during winter would ceteris paribus result in decline in prescribed LED, and conversely a decrease in dopamine during summer would result in an increase in LED. Furthermore, the analysis of meteorological data supplied by the BoM allowed us to identify temperature as causal mechanisms.
Our study is an ecological study, and our findings are exploratory rather than definitive. We cannot categorically rule out the possibility that other seasonal environmental and/or behavioural phenomena correlated with temperature could affect the LED. Our empirical models implicitly assume that once the average monthly seasonal effect is controlled for, (e.g. with the set of monthly dummy variables in model 1), the unobserved seasonal factors will be randomly distributed around the monthly mean. However, we are reasonably confident in the capacity of models to control for unobserved seasonal factors. Temperature and UV light are highly correlated (0.79), yet both models report a statistically significant relationship between LED and temperature but not UV light, or its lags. This suggests that an unobserved seasonal variable would need to be highly correlated with temperature, to confound our analysis. Hence, we cautiously suggest that results can be interpreted as evidence of a causal relationship between temperature and the LED. Undoubtedly, further work, in different study designs, is needed to confirm the findings.
If confirmed, these results have some important implications for our understanding of PD and raise possible avenues for treatment and symptom amelioration. The brain is recognised as the most heat-sensitive organ in the body (Kiyatkin 2010) . Research which identified how temperature may affect the symptoms of Parkinson's disease would improve our future understanding of the pathophysiology of this neurological disease. . 
